Metabolic parameters as possible diagnostic predictors in first‐episode psychosis: An exploratory retrospective cohort study
- 22 November 2021
- journal article
- research article
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 16 (11) , 1171-1174
Abstract
Aim: Patients in early phases of schizophrenia or mood disorders with psychotic symptoms have a wide array of metabolic abnormalities. We analysed the potential predictive value of uric acid (UA) levels and other metabolic parameters in first‐episode psychosis patients to differentiate between non‐affective and affective psychosis.Methods: Retrospective chart review of all patients referenced to a first‐episode psychosis unit (n = 149), between 2012 and 2017, with available UA levels. Patients included (n = 37) were compared according to the follow‐up diagnosis of schizophrenia or mood disorder.Results: Mood disorder patients presented higher UA levels (p = .030) and lower fasting blood glucose levels (p = .020) compared with schizophrenia patients. The remaining variables did not show significant intergroup differences.Conclusions: Findings in this first‐episode psychosis cohort support previous evidence suggesting higher UA levels as a predictor of affective psychosis and glucose dysfunction as predictive of schizophrenia. Further studies are needed to explore metabolic parameters as possible diagnostic predictors in first‐episode psychosis.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (PTDC/MEC‐PSQ/30943/2017, PTDC/NEU‐SCC/7051/2014, UIDB/04539/2020)
This publication has 21 references indexed in Scilit:
- Challenges and developments in research of the early stages of bipolar disorderBrazilian Journal of Psychiatry, 2016
- Biomarkers in schizophrenia: A focus on blood based diagnostics and theranosticsWorld Journal of Psychiatry, 2016
- Glucose disturbances in first-episode drug-naïve schizophrenia: Relationship to psychopathologyPsychoneuroendocrinology, 2015
- Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorderDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2015
- A systematic review and meta-analysis of premature mortality in bipolar affective disorderActa Psychiatrica Scandinavica, 2015
- Immune system and glucose metabolism interaction in schizophrenia: A chicken–egg dilemmaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2014
- Potential metabolite markers of schizophreniaMolecular Psychiatry, 2011
- Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episodeProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
- Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?International Clinical Psychopharmacology, 2008
- Reduced plasma antioxidants in first-episode patients with schizophreniaSchizophrenia Research, 2003